Related references
Note: Only part of the references are listed.Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells
Nadra Sadaf et al.
LIFE SCIENCES (2018)
Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements
Christopher R. Nitkin et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Evolving role of Sorafenib in the management of hepatocellular carcinoma
Ioannis A. Ziogas et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation
Premalatha Shathasivam et al.
BRITISH JOURNAL OF CANCER (2017)
Neurotrophic factor mediated neuronal differentiation of human cord blood mesenchymal stem cells and their applicability to assess the developmental neurotoxicity
Sadaf Jahan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Comparative Analysis of Human Mesenchymal Stem Cells Derived From Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy
Young-Joo Jeon et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy
Tzu-I Chao et al.
CANCER LETTERS (2016)
Genetically modified mesenchymal stromal cells in cancer therapy
Elizabeth K. Sage et al.
CYTOTHERAPY (2016)
Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling
Yulyana Yulyana et al.
MOLECULAR THERAPY (2015)
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma
Xiufeng Jiang et al.
ONCOTARGET (2015)
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
Victor Ho et al.
ONCOTARGET (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts
Yanan Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression
Juliana Passos Paschoal et al.
BMC CANCER (2014)
Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth
Stefania Bruno et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
Pratika Y. Hernanda et al.
CARCINOGENESIS (2013)
Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis
Xin-Long Yan et al.
HEPATOLOGY (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study
Tianran Li et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2013)
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
Yafei Zhang et al.
CLINICS (2012)
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
Ying-Hong Shi et al.
AUTOPHAGY (2011)
Mesenchymal Stem Cells: Angels or Demons?
Rebecca S. Y. Wong
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Hepatocellular Carcinoma: Agents and Concepts for Preventing Recurrence After Curative Treatment
Hans J. Schlitt et al.
LIVER TRANSPLANTATION (2011)
Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
Ann H. Klopp et al.
STEM CELLS (2011)
Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line
Guo-Cai Li et al.
CANCER SCIENCE (2010)
Tumor cell behaviour modulation by mesenchymal stromal cells
Lucia Kucerova et al.
MOLECULAR CANCER (2010)
Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway
Venkata Ramesh Dasari et al.
PLOS ONE (2010)
Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP)
Venkata Ramesh Dasari et al.
PLOS ONE (2010)
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
Keishi Otsu et al.
BLOOD (2009)
Hyperthermia-treated Mesenchymal Stem Cells Exert Antitumor Effects on Human Carcinoma Cell Line
Jung Ah Cho et al.
CANCER (2009)
Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo
Beatrice Cousin et al.
PLOS ONE (2009)
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling
Ling Qiao et al.
CANCER LETTERS (2008)
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Ling Qiao et al.
CELL RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Opportunities and obstacles to combination targeted therapy in renal cell cancer
Jeffrey A. Sosman et al.
CLINICAL CANCER RESEARCH (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
Anne M. Lewis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
Wei Zhu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Aarif Y. Khakoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma
RE Omer et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Comparison of multi-lineage cells from human adipose tissue and bone marrow
DA De Ugarte et al.
CELLS TISSUES ORGANS (2003)
Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix
LB Ohlsson et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2003)
Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain
YH Jiang et al.
EXPERIMENTAL HEMATOLOGY (2002)
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
C Campagnoli et al.
BLOOD (2001)
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors
HE Young et al.
ANATOMICAL RECORD (2001)
Mesenchymal progenitor cells in human umbilical cord blood
A Erices et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Mesenchymal precursor cells in the blood of normal individuals
NJ Zvaifler et al.
ARTHRITIS RESEARCH (2000)
Share Paper
